Clonal proliferative disorder via BRAF V600E mutation, MAP2K1 mutation, or activation of MAPK/ERK has been considered as possible pathogenesis for LCH.[7–9] Furthermore, LCH shares characteristics of children dominance and variable severity. Here, MAP2K1 is linked to Langerhans cell histiocytosis.